System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Gerd R Burmester is an expert in Rheumatology at Charité - University Medicine Berlin (Germany). As of October 2026, ScienceLeadR ranks Gerd R Burmester in the top 1% of experts worldwide for Arthritis, Autoimmune Diseases and Synovitis. Gerd R Burmester has authored 1,435 publications, the most recent in 2026, and is an investigator in 53 clinical trials, 2 of them ongoing. SLR score: 4,776 (community average: 125). How the SLR is computed.

LeadR Profile

Gerd R Burmester Charité - University Medicine Berlin Germany
4 776 ScienceLeadR Reputation 4776

Unlock

Register Login
Network Map

Rheumatology

Subspecialties: Pharmacy - Immunology - Internal Medicine

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1987 - 2026
Source: PubMed

Charité - University Medicine Berlin

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 1435

Citations

Citations: 100 869 1st author: 144 Last author: 279 Unique author: 18

Main journals

Ann Rheum Dis 458
Z Rheumatol 86
Arthritis Rheum 77
Rheumatology (Oxford) 73
Arthritis Res Ther 66

Best Journals

N Engl J Med 3
Nat Rev Rheumatol 2
Lancet 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Corrigendum to 'Comparison of the PK, PD, safety, tolerability, and immunogenicity of proposed biosimilar RGB-19 and tocilizumab in healthy Japanese males: a phase 1, randomised, crossover study' [EULAR Rheumatology Open 1 (2025) 282-290].
PMID 42871760 — rheumatology, safety, cross-over studies, biosimilar pharmaceuticals		EULAR Rheumatol Open20260
Addressing the global impact of rheumatology research: preface to the Viewpoint Series in EULAR Rheumatology Open on the progress in international rheumatology.
PMID 42539932 — rheumatology, research		EULAR Rheumatol Open20260
Filgotinib in Moderate to Severe Rheumatoid Arthritis in a Real-World Setting: Up to 6-Month Effectiveness, Patient-Reported Outcomes, and Persistence, and up to 24-Month Safety from More than 1400 Patients in the FILOSOPHY and PARROTFISH Studies.
PMID 42536126 — safety, pain, arthritis, arthritis, rheumatoid, patient reported outcome measures, therapeutics		Rheumatol Ther20260
Efficacy, safety, and immunogenicity of proposed biosimilar RGB-19 and tocilizumab intravenously administered to adults with active rheumatoid arthritis and an inadequate response to methotrexate: a phase 3, randomised study.
PMID 42370118 — safety, serum, incidence, pharmaceutical preparations, arthritis, drug-related side effects and adverse reactions, arthritis, rheumatoid, therapeutics, methotrexate, biosimilar pharmaceuticals		EULAR Rheumatol Open20260
Artificial intelligence in healthcare faces regulatory challenges: balancing innovation with human oversight.
PMID 42370110 — intelligence, risk management, artificial intelligence		EULAR Rheumatol Open20261

Clinical Studies 53

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

Phase 3 30
N/A 8
Phase 2 7
Phase 1 3
Phase 4 3
Phase 1/Phase 2 2

By status:

Completed 41
Terminated 4
Unknown 4
Recruiting 2
Active not recruiting 1
Not yet recruiting 1

By type:

Interventional 48
Observational 5

By Monocentric/Multicentric:

monocentric 16
multicentric2to4 0
multicentric5to9 2
multicentricup10 35

Main Topics

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Study to Evaluate Usability of Subcutaneous Auto injector of CT P47 in Patients With Active Rheumatoid Arthritis
NCT05725434 — injections, syringes, arthritis, arthritis, rheumatoid, artificial intelligence		Phase 3Not yet recruiting2023
Compare the Auto injector and Pre filled Syringe of CT P47 in Healthy Subjects
NCT05617183 — injections, safety, syringes, healthy volunteers, artificial intelligence, pharmacokinetics		Phase 1Recruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS